Yahoo
OTC Markets OTCID USD

Altamira Therapeutics Ltd. (CYTOF)

0.0710 -0.0320 (-31.07%)
At close: October 30 at 4:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Cost of Revenue
--
--
268.9347
1,557.3214
2,451.1038
Gross Profit
--
--
-80.5724
-1,227.6884
-2,381.2187
Operating Expense
5,633.3220
6,921.7400
6,601.1120
18,862.7430
7,517.0660
Operating Income
-5,633.3220
-6,921.7400
-6,601.1120
-18,862.7430
-7,517.0660
Net Non Operating Interest Income Expense
-47.8120
-16.4760
-812.6820
-827.3060
14.0882
Other Income Expense
28.2060
-1,519.5320
-677.5130
151.2390
57.1557
Pretax Income
-5,652.9280
-8,457.7480
-8,091.3070
-19,538.8100
-7,445.8221
Tax Provision
--
0
0
-8.2920
-129.0286
Net Income Common Stockholders
-5,652.9280
-8,457.7480
-4,306.2600
-27,778.4430
-18,661.4626
Diluted NI Available to Com Stockholders
-5,652.9280
-8,457.7480
-4,306.2600
-27,778.4430
-18,661.4626
Basic EPS
-1.19
-2.99
-16.47
-428.90
-563.52
Diluted EPS
-1.19
-2.99
-16.47
-428.90
-563.52
Basic Average Shares
4,310.4880
2,832.2990
491.2580
45.5360
33.1160
Diluted Average Shares
4,310.4880
2,832.2990
491.2580
45.5360
33.1160
Total Operating Income as Reported
-5,562.4960
-6,850.9140
-6,584.4180
-18,862.7430
-7,517.0660
Rent Expense Supplemental
--
55.3160
17.4790
6.2840
57.1929
Total Expenses
5,633.3220
6,921.7400
6,601.1120
18,862.7430
7,517.0660
Net Income from Continuing & Discontinued Operation
-5,652.9280
-8,457.7480
-4,306.2600
-27,778.4430
-18,661.4626
Normalized Income
-6,677.6710
-7,640.7630
-7,441.1250
-19,681.6928
-7,372.9588
Interest Income
2.8140
3.3270
336.3930
119.6520
29.5263
Interest Expense
50.6260
19.8030
1,149.0750
946.9580
15.4381
Net Interest Income
-47.8120
-16.4760
-812.6820
-827.3060
14.0882
EBIT
-5,602.3020
-8,437.9450
-6,942.2320
-18,591.8520
-7,430.3840
EBITDA
-5,458.6050
-8,310.8910
-6,809.4510
-18,467.3630
-7,346.8515
Reconciled Cost of Revenue
--
--
268.9347
1,557.3214
2,400.0864
Reconciled Depreciation
143.6970
127.0540
132.7810
124.4890
83.5324
Net Income from Continuing Operation Net Minority Interest
-5,652.9280
-8,457.7480
-8,091.3070
-19,530.5180
-7,316.7936
Total Unusual Items Excluding Goodwill
1,024.7430
-816.9850
-650.1820
151.2390
57.1557
Total Unusual Items
1,024.7430
-816.9850
-650.1820
151.2390
57.1557
Normalized EBITDA
-6,483.3480
-7,493.9060
-6,159.2690
-18,618.6020
-7,404.0072
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0.0642
0.9904
12/31/2021 - 8/6/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: